BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 22800421)

  • 21. [Generation of engineering Th17 cells and its function evaluation].
    Zhang HX; Chen C; Zeng LY; Zhang Y; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):825-9. PubMed ID: 22339955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory effects of IFN-β on the development of experimental autoimmune uveoretinitis in B10RIII mice.
    Sun M; Yang Y; Yang P; Lei B; Du L; Kijlstra A
    PLoS One; 2011 May; 6(5):e19870. PubMed ID: 21573074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.
    Mus AM; Cornelissen F; Asmawidjaja PS; van Hamburg JP; Boon L; Hendriks RW; Lubberts E
    Arthritis Rheum; 2010 Apr; 62(4):1043-50. PubMed ID: 20131264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.
    Sonderegger I; Kisielow J; Meier R; King C; Kopf M
    Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12.
    Yokoi H; Kato K; Kezuka T; Sakai J; Usui M; Yagita H; Okumura K
    Eur J Immunol; 1997 Mar; 27(3):641-6. PubMed ID: 9079803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
    Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excess IL-1 signaling enhances the development of Th17 cells by downregulating TGF-β-induced Foxp3 expression.
    Ikeda S; Saijo S; Murayama MA; Shimizu K; Akitsu A; Iwakura Y
    J Immunol; 2014 Feb; 192(4):1449-58. PubMed ID: 24431229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TGF-beta-exposed plasmacytoid dendritic cells participate in Th17 commitment.
    Bonnefoy F; Couturier M; Clauzon A; Rémy-Martin JP; Gaugler B; Tiberghien P; Chen W; Saas P; Perruche S
    J Immunol; 2011 Jun; 186(11):6157-64. PubMed ID: 21518970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenic Function of Herpesvirus Entry Mediator in Experimental Autoimmune Uveitis by Induction of Th1- and Th17-Type T Cell Responses.
    Sakoda Y; Nagai T; Murata S; Mizuno Y; Kurosawa H; Shoda H; Morishige N; Yanai R; Sonoda KH; Tamada K
    J Immunol; 2016 Apr; 196(7):2947-54. PubMed ID: 26912321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The changes of Th lymphocyte subsets in patients with Behcet disease].
    Liang L; Wang H; Peng XY; Zhao M
    Zhonghua Yan Ke Za Zhi; 2011 May; 47(5):393-7. PubMed ID: 21756739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
    Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis.
    Ohshima M; Yamahara K; Ishikane S; Harada K; Tsuda H; Otani K; Taguchi A; Miyazato M; Katsuragi S; Yoshimatsu J; Kodama M; Kangawa K; Ikeda T
    J Mol Cell Cardiol; 2012 Sep; 53(3):420-8. PubMed ID: 22796574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis.
    Xu H; Rizzo LV; Silver PB; Caspi RR
    Cell Immunol; 1997 May; 178(1):69-78. PubMed ID: 9184700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
    Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation.
    Kalim KW; Basler M; Kirk CJ; Groettrup M
    J Immunol; 2012 Oct; 189(8):4182-93. PubMed ID: 22984077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immune state of Th1, Th2 and Th17 subpopulation in experimental autoimmune myocarditis].
    Han LN; Li TL; Zhang YJ; Yang TS; Ding Y; Guo SL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):751-6. PubMed ID: 22332535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leucine-Rich Repeat Kinase 2 (Lrrk2) Deficiency Diminishes the Development of Experimental Autoimmune Uveitis (EAU) and the Adaptive Immune Response.
    Wandu WS; Tan C; Ogbeifun O; Vistica BP; Shi G; Hinshaw SJ; Xie C; Chen X; Klinman DM; Cai H; Gery I
    PLoS One; 2015; 10(6):e0128906. PubMed ID: 26067490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis.
    Peng Y; Han G; Shao H; Wang Y; Kaplan HJ; Sun D
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4153-61. PubMed ID: 17724201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
    Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Treg/Th17 imbalance in Toxoplasma gondii-infected pregnant mice.
    Zhang H; Hu X; Liu X; Zhang R; Fu Q; Xu X
    Am J Reprod Immunol; 2012 Feb; 67(2):112-21. PubMed ID: 21923716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.